Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Again i just want to say about SONN that in my opinion it is not a COVID-19 play and i own no stock and think it may be over priced in my opinion
IMO watch out with the SONN. I do not believe it is really a COVID-19 stock play. Do not be surprised if there is a drop in the stock imo. i do not own SONN
Read an interesting article over weekend. MTDR huge insider buying this quarter. earnings come out 4/29.
GLD --gold miners index should market go down and the COPX copper index possibly poised to make move should market go down.
i have been plating the DPST 3x bank index and making some money. it was 54 2 months ago and 7 and change today with some huge swings.
Shorts could be trading it up,taking profits and shorting. They are still in stock imo
It has been released 3 days ago
do you have a link to that interview with Bloomberg?
For what it is worth heavy insider buying on MTDR
zhang,
i do not see that they have EAU approval. i was going to buy on open and pulled my order. PRED should come out and debunk each claim made by Hidenburg in my opinion. I am long on PRED, i have what i have but i do not want to be cut off at the knees again. i do not think Stock Guru's analysis addressed Hindenburg's allegations. I need to be convinced. So far i see Cellex and Abbot as the approved EAU suppliers of kits
someone debunk Hidenburg's allegations:
https://hindenburgresearch.com/predictive-covid/
Can someone show me a link where PRED has received EAU approval for their 15 minute test?
Last week you said PRED was a .20 cent stock. Now it is $30 stock and you said you do not speak to anyone in company. Prior to saying it was worth .20 you said it was buy at .80. How do you reconcile your numbers?
I agree with you, but i think they just diluted some shares. The drug is in clinical 2 trials with good results. it is better than having your testicles removed.........which reminds me of a joke. Guy is on a nude beach and sees a guy 100 lbs, 50 lbs, of that is his testicles. The man says i feel sick, The other guy says you are not sick you are 1/2 nuts
I am certainly not as savvy as you guys on this board but BURG at .41 jumped to $1 after my post. A nice 125% move(:).
BURG.................Last day to get spin off. Record date TODAY. Closing deal to get spin off. Could run again.. Home Delivery like Blue Apron. Was $2 last week.
Robert Hirsh assuming all the debt...smart guy....cheap properties with this epidemic...enviable position to capitalize on buying discounted asssets.
Have to be holder of record of BURG on 3-26 to get the bio-tech stock. could have another APRON in the making with huge food delivery system If you want to get the distribution pile in now
Taking 2nd bite with burg here
Seems to be holding in this market
Running up. From .36 to .33?
Topknotch,
We will see when the numbers come out
Peachman,
All I said was he posted a link and PRED was not a sponsor. I also said that he has essentially disappeared off the board. how can this go from $1 to $50 by end of year.
Piper,
Yeah maybe he will come out with a pressed shirt. I think the disappearance of Thomas imo opinion may be that he was working for company and posting anonymously....left company and dumped his shares
Patience in Waiting
The time to have addressed the hit piece was when it came out and they did nothing. The great Thomas has disappeared from the board so $50 by end of year is a fantasy. This company addresses nothing
Shorts not issue. Warrants and free shares. Company was so stupid I hear they neglected to restrict the shares
They increased float for reverse split which is why imo people are stating float will decline
I have heard that it was someone in company who quit and has been unloading thousands of free shares. it is warrants and free shares selling
How many shares are free paper coming due?
Predictive Laboratories Launches FertilityDX™
Genetic testing service now available to identify causes of infertility and guide personalized fertility treatments
SALT LAKE CITY, Oct. 14, 2019 (GLOBE NEWSWIRE) -- Predictive Laboratories, a wholly owned molecular and genetic diagnostics company of Predictive Technology Group (OTC Pink: PRED) focused on hard-to-detect diseases, women’s health and infertility, announces the launch of FertilityDX™, a comprehensive genetic testing service that identifies barriers to healthy pregnancy and birth, allowing doctors to tailor fertility treatments. The test launch will be formally announced at the American Society for Reproductive Medicine (ASRM) 2019 Scientific Congress and Expo, Oct. 12-16 in Philadelphia.
“For the one in eight couples who struggle with infertility, trying to have a child can be financially, physically and emotionally exhausting—largely because the couple doesn’t know why they are having difficulty conceiving,” said Kenneth Ward, M.D., Laboratory Director of Predictive Laboratories. Dr. Ward is a board-certified physician in obstetrics and gynecology, perinatology, clinical genetics and molecular genetics. “Our desire is to arm couples considering assisted reproductive technologies (ART) with an understanding of the genetic and medical obstacles that may be affecting their fertility and provide doctors with genetically relevant information to help their patients have a healthy baby.”
FertilityDX provides information by evaluating three key areas: contributors to (or causes of) infertility, risks of pregnancy complications, and risks for serious genetic conditions in offspring.
FertilityDX supports both physician and patient throughout the entirety of the treatment process. Patients are provided with pretest counseling and clear and relevant test results. Physicians get an easy-to-understand final report and access to a variety of genetics consultants. The test will be launched in select fertility clinics across the United States, offering couples access to the most comprehensive genetic service to date.
About Predictive Laboratories
Predictive Laboratories’ discoveries in molecular and genetic diagnostics focus on unmet needs in women’s health, infertility and other diseases. Predictive Laboratories offers earlier detection of disease through genetic assessment to guide personalized precision medicine. Leveraging its vast genetic database, Predictive Laboratories enables the discovery of genes and gene mutations that identify hard-to-diagnose and detect diseases and their prognosis.
The Company’s proprietary tests include ARTguideTM and FertilityDXTM. ARTguide is a blood test that assesses a woman’s endometriosis risk and other genetic causes of infertility in order to optimally navigate the path towards conception. FertilityDX is a comprehensive test and service, using the parental genetic assessment as the map to guide the journey to successful pregnancy and a healthy newborn. Predictive Laboratories’ tests are processed at the Company’s state-of-the-art CAP-accredited, CLIA-certified laboratory, equipping physicians with the robust diagnostic tools to provide personalized treatment for their patients. For more information, visit www.predictivelabs.com.
About Predictive Technology Group, Inc.
Predictive Technology Group aims to revolutionize and personalize precision patient care. The Company’s entities harness predictive gene-based analytics to develop genetic and molecular diagnostic tests, as well as companion therapeutics, to support a patient from diagnosis through treatment. The companies’ tests and products empower clinicians to provide their patients with the highest level of care. Predictive’s subsidiaries include Predictive Laboratories, Predictive Biotech and Predictive Therapeutics. For more information, visit www.predtechgroup.com.
Forward-Looking Statements:
To the extent any statements made in this release contain information that is not historical, these statements are essentially forward-looking and are subject to risks and uncertainties, including the difficulty of predicting FDA approvals, acceptance and demand for human cell and tissue products and other pharmaceutical products, the impact of competitive products and pricing, new product development and launch, reliance on key strategic alliances, availability of raw materials, availability of additional intellectual property rights, availability of future financing sources, the regulatory environment, and other risks the Company may identify from time to time in the future.
Media Contact:
Holly Dugan
predictive@antennagroup.com
201-465-8019
Investor Contacts:
LHA Investor Relations
Jody Cain
jcain@lhai.com
Kevin McCabe
kmccabe@lhai.com
310-691-7100
Disagree.........there are a lot of exerciseable warrants out there. There seems to be a lot more paper than I thought.
I think the loss widened because the spent $4 mil more on R&D and cost of goods increased a couple of million. when you factor those things in that could account for the loss.....but sales were up!
Stock Guru,
Are you sure they will be released after the close?
With regard to the earnings the 23rd was just a projection and unconfirmed by TD Ameritrade. Last time were the earnings not released on 5/21? The earnings need to be very good to alleviate the negativity on the board. also I have not picked up on any insider transactions which can be taken as a positive
PER TD:
(Unconfirmed) September 23, 2019 is earnings date. Will the earnings come out on time? Any opinions on the matter?
The stock will begin to move up if the earnings comes out and they are good and have increased for the 13th straight quarter. If they are not good the stock is dead in the water. That is my opinion
Biigboy,
You do not walk into China and just start to do business. My relative has a plant there I know
Stock Guru,
I ate Chinese the other night as well. Not with chop sticks though. We then put the garbage in the container to Poland marked IPWG. Ring any bells?
Thomas,
First of all I am long and we are through the week and I see nothing happening. I would have thought you knew that silver manipulation has always been in the news
thomas,
That was 9 years ago. Tell me something I do not know. Did you mention that nothing happened in the end? They could not prove the manipulation
Thomas,
The last picture you posted he was in NASDAQ allegedly learning how to ring the bell, the implication being PRED was going on NASDAQ. The only bell that got rung because of that was mine.
Now you claim the picture posted was taken in Hong Kong and he had a pen and paper in his hand. For what purpose? How do we know he was in Hong Kong?
Stockboy,
They were actually long on it between $23 and $24 a share and touted it would soon be $100.00 I guess they are getting what they deserve now. !
TD says as to earnings:
(Unconfirmed) September 20, 2019
That is the date they reference under symbol on right hand of page when you check the price of your stock